European Innovation
€100,000 in grant funds
Winners
AlphaBiomics develops microbiome-based precision medicine solutions to predict drug response and improve drug therapy. By deciphering how gut microbiome influences individual responses to medicines, AlphaBiomics predicts how well individuals will respond to particular therapies and designs companion therapeutics to boost patient response to their medicines. AlphaBiomics will employ their platform to deliver safer and more efficacious immunotherapy in autoimmune diseases.
The Challenge
The European Pharmaceutical Market is projected to grow from €169 Billion in 2015 to €206 Billion in 2022. (source). One of the 20th century's most innovative pharmaceutical researchers - Dr. Paul Janssen - first established Janssen Pharmaceutica N.V. in Europe more than six decades ago and lay the foundation for the discovery and development of more than 80 new medicines. That Belgian biotech industry alone funneled €3.4 billion into research and development in 2016, a staggering increase of 123% compared to 10 years earlier.
In celebration of and collaboration with these strides in human healthcare, Johnson & Johnson Innovation Limited and Johnson & Johnson Innovation, JLABS have launched the European Innovation QuickFire Challenge. The innovator with the best idea, technology, or solution that improves human healthcare and impacts the European ecosystem will receive up to €100,000 in grants as well as a voucher for one year of residency at an available JLABS locations, including a laboratory bench, workstation and access to the global JLABS community.
JLABS is continuing to expand towards a truly global open innovation ecosystem by nurturing breakthrough science at a growing network of JLABS locations, including upcoming launches spanning from New York City to Shanghai. This unique model provides entrepreneurs with access to state-of-the-art infrastructure, expertise, and funding opportunities in a no-strings-attached environment.
Rewards and benefits
- 1 year residency at an available JLABS locations
- Access to the global JLABS network
Areas of Interest
我们鼓励从事人类医疗方面各个方面的公司的申请，并在以下领域特别感兴趣：
- Pharmaceuticals
- Consumer products
- Medical devices
- Global public health
- Health technologies
- Cross sector initiatives
Why this challenge matters to us:
At Johnson & Johnson Innovation, we believe a good idea can come from anywhere, and it's our goal to find new and innovative technologies that provide solutions to patients from across the world. Working together, we can spark the next great idea that will change the trajectory of health.
常见问题tions
Make sure your browser is up to date and accepting cookies. You can contact customer service athttps://jnjawards.fluidreview.com/helpdesk/contact/if you are having technical difficulties as well.
For challenges involving residency at JLABS, that entails 1 lab bench and 1 workstation (desk) for 2 people maximum. If you have more employees, we can rent out an additional residency.
Each applicant will be required to submit to a background check, which is subject to a minimal fee. We also collect a deposit that is refundable at the end of the lease term. There may be other expenses, but this will be dependent on the work that the company is doing in JLABS. There may also be fees associated with EH&S waste, specialty equipment, printing and phone calls.
No, any additional fees and paperwork are up to the winner.
您将有机会，并鼓励您上传支持材料，例如幻灯片，研究论文和视频，作为您应用程序的一部分。您可以提交视频以及打字的响应。最大长度为2分钟。
Do not submit confidential information. Only non-confidential information should be submitted and anything you submit will be treated as non-confidential.
As this is a no strings attached arrangement, JLABS does not acquire any IP. Any IP creation and/or protection remains the sole responsibility of the inventors.
No, a patent is not required to apply. However, you should not submit any information that you wish to keep confidential or that may negatively impact upon the future patentability of your invention.
We encourage all to apply. Find out more about what areas we desire to explore here:https://www.jnjinnovation.com/partnering
Each Challenge has its own terms & conditions that can be found prior to filling out the application.
Solutions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria:
- Potential impact
- Uniqueness of solution & level of competition in current market
- Quality & feasibility of technology
- Team credibility & capabilities
- Plans for utilizing JLABS residency
- Idea submission outlines interest in the innovation ecosystem in Europe
Please contact[email protected]with any questions.
You can setup an account athttp:// jnjawards.fluidreview.com。You are able to save your work and log back in to finish at a later time if needed.
Application Process:
Solutions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria:
- Potential impact
- Uniqueness of solution & level of competition in current market
- Quality & feasibility of technology
- Team credibility & capabilities
- Plans for utilizing JLABS residency
- Idea submission outlines interest in the innovation ecosystem in Europe
Timeline
About Johnson & Johnson Innovation, JLABS
强生公司创新,JLABS (JLABS)是一个global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors.
JLABS目前在世界各地的创新热点地区都有地点，并制作了企业家计划和运动，以寻求最好的科学，例如全球的Quickfire挑战。乐动体育为什么赞助西甲JLABS旗舰店于2012年在圣地亚哥的Janssen西海岸研究中心开业，从那时起，在旧金山建立了两个地点 - 一个通过与加利福尼亚州定量生物科学研究所（QB3）合作，在South San san San San San San San San San San San San San San San Sandity建立了两个地点。弗朗西斯科。JLABS还通过与德克萨斯州医疗中心（TMC）的合作，通过与安大略省政府和多伦多大学的多伦多合作，通过与休斯敦的UMass合作，通过与UMASS合作在马萨诸塞州洛厄尔的Labcentral合作，位于波士顿。。。有关JLABS的更多信息，请访问www.www.2574design.com。
About Johnson & Johnson Innovation
Johnson & Johnson Innovation Limited focuses on accelerating early-stage innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation – JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information, visitwww.jnjinnovation.comor follow @JNJInnovation